Cafepharma Today

February 7 2025 - Novo Nordisk plans new study for CagriSema, targets 2026 submission
Novo Nordisk plans new study for CagriSema, targets 2026 submission
Musk's team accesses Medicare, Medicaid records
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

AstraZeneca profit up, reiterates guidance
Marketwatch
Thursday, April 30, 2009 - 7:29am
tags:
AstraZeneca, earnings
Stock Picks: 6 Health Care—Stimulus Plays
CNBC
Thursday, April 30, 2009 - 7:26am
tags:
Luminex, GSK, Sanofi, Novartis, Illumina, United Health
Lilly, Amylin sign exenatide deal
Bizjournals.com
Thursday, April 30, 2009 - 7:25am
tags:
Eli Lilly, Amylin, exenatide, partnerships
Merck KGaA Pill Cuts MS Relapse Risk in Half, With Side Effects
Bloomberg
Thursday, April 30, 2009 - 7:24am
tags:
Merck KGaA, multiple sclerosis, MS, cladribine
Pfizer’s Lipitor Cuts Risk of a Second Stroke in Patients
Bloomberg
Thursday, April 30, 2009 - 6:17am
tags:
Pfizer, Lipitor, stroke
Novartis says Aflunov could have broader use
Marketwatch
Thursday, April 30, 2009 - 6:16am
tags:
Novartis, Flu, swine flu, Aflunov
ZymoGenetics laying off 32 percent of staff
Yahoo/AP
Wednesday, April 29, 2009 - 10:18pm
tags:
ZymoGenetics, layoffs, Bristol-Myers Squibb
Wyeth Shares Tread Water
Yahoo/Zacks.com
Wednesday, April 29, 2009 - 6:13pm
tags:
Wyeth, Pfizer
2 Lessons From Dendreon
Motley Fool
Wednesday, April 29, 2009 - 6:13pm
tags:
Dendreon, Provenge, prostate cancer
Pharmaceutical Stocks Remain a Buy
Seeking Alpha
Wednesday, April 29, 2009 - 6:11pm
tags:
Forest Labs, Bristol-Myers Squibb, JNJ, GSK, Eli Lilly, Merck, Novartis, Pfizer
Bullish On Bristol-Myers
Seeking Alpha
Wednesday, April 29, 2009 - 10:10am
tags:
Bristol-Myers Squibb, Exelixis, ZymoGenetics
Personalized Medicine: The Next Big Thing
Seeking Alpha
Wednesday, April 29, 2009 - 10:03am
tags:
personalized medicine
Isis and Alnylam Form New Collaboration to Develop Single-Stranded RNAi Technology
Yahoo
Wednesday, April 29, 2009 - 9:11am
tags:
Isis Pharmaceuticals, Alnylam, RNAi, partnerships
Peregrine reports positive data from second Phase II breast cancer trial
Pharmaceutical Business Review
Wednesday, April 29, 2009 - 8:58am
tags:
Peregrine Pharmaceuticals, data trials, breast cancer
Wyeth wins European approval for osteoporosis drug
Pharmaceutical Business Review
Wednesday, April 29, 2009 - 8:57am
tags:
Wyeth, Europe, osteoporosis, CONBRIZA
Endo Pharma 1Q Net Drops 34% On Acquisition Costs
WSJ Online
Wednesday, April 29, 2009 - 8:43am
tags:
Endo, earnings
Supreme Court Denies Aventis' Cert Petition in Lovenox Case
Seeking Alpha
Wednesday, April 29, 2009 - 8:41am
tags:
Sanofi, Supreme Court, Lovenox
United Therapeutics says FDA now plans to rule on inhaled blood pressure drug by July 30
Yahoo/AP
Wednesday, April 29, 2009 - 7:38am
tags:
United Therapeutics, FDA, hypertension, Tyvaso
5 Potential Pandemic Shorts
Seeking Alpha
Wednesday, April 29, 2009 - 7:35am
tags:
Biocryst, Novavax, Crucell, Cerus, Gilead Sciences
Sanofi-Aventis to halt work on 3 Phase III experimental drugs after pipeline review
Yahoo/AP
Wednesday, April 29, 2009 - 7:34am
tags:
Sanofi, pipelines, Saredutant, TroVax, Unifive

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Today’s Rare Disease Launches Require the Right Specialty Pharmacy Partner
Drug Channels
An Evaluation of "Deep Research" Performance
In the Pipeline
The Continuing NIH/NSF Crisis, Part II
In the Pipeline
Revised and Extended: What's Happening Inside the NIH and NSF
In the Pipeline
What's Happening Inside the NIH and NSF
In the Pipeline
Vertical Integration Redux: How Pharmaceutical Wholesalers Are Transforming the Buy-and-Bill Market (Video)
Drug Channels
Informa Connect's Access USA
Drug Channels
Fresh Asteroid, Getcher Fresh Asteroid Here
In the Pipeline
Unlocking AI’s Promise in Patient Support Programs
Drug Channels

Latest Jobs

Cell Therapy Navigator
Houston, Texas, 77002
Inizio Engage
Rapid Deployment Representative
Fort Worth, Texas, 76102
Inizio Engage
Rapid Deployment Representative
Charlotte, North Carolina, 28245
Inizio Engage
Oncology Key Account Manager
Newark, New Jersey, 07175
Inizio Engage
Cell Therapy Navigator
Little Rock, Arkansas, 72208
Inizio Engage
Territory Business Manager
Philadelphia, Pennsylvania, 19107
Inizio Engage
Business Development Representative
Las Vegas, Nevada, 89105
Professional Case Management
Oncology Key Account Manager
Atlanta, Georgia, 30383
Inizio Engage
Territory Manager, Surgical Pain - South Houston, TX
TX,
Avanos Medical
Neurology Account Manager- MD/DC/N VA (Remote)
Annapolis, Maryland, 21401
Jazz Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information